We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
+2.01%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$3.48B
AUM Growth
+$211M
Cap. Flow
+$149M
Cap. Flow %
4.28%
Top 10 Hldgs %
63.27%
Holding
329
New
32
Increased
177
Reduced
75
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 4.12%
2 Financials 2.19%
3 Communication Services 1.35%
4 Healthcare 0.61%
5 Consumer Discretionary 0.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVS icon
251
Novartis
NVS
$302B
$363K 0.01%
2,631
+728
+38% +$95.3K
IGSB icon
252
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$357K 0.01%
6,754
+150
+2% +$7.94K
COP icon
253
ConocoPhillips
COP
$144B
$356K 0.01%
3,804
+461
+14% +$41.7K
CB icon
254
Chubb
CB
$140B
$351K 0.01%
1,124
+301
+37% +$88K
RLJ.PRA icon
255
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
$324M
$348K 0.01%
13,980
SCHZ icon
256
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$348K 0.01%
14,874
-1,954
-12% -$45.9K
TMUS icon
257
T-Mobile US
TMUS
$195B
$344K 0.01%
1,694
+210
+14% +$44.5K
NUEM icon
258
Nuveen ESG Emerging Markets Equity ETF
NUEM
$354M
$342K 0.01%
9,622
MDT icon
259
Medtronic
MDT
$112B
$342K 0.01%
3,559
+324
+10% +$31.5K
BA icon
260
Boeing
BA
$169B
$339K 0.01%
1,561
+293
+23% +$60.3K
SPDW icon
261
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$39.3B
$338K 0.01%
+7,604
New +$332K
VGK icon
262
Vanguard FTSE Europe ETF
VGK
$30.1B
$336K 0.01%
4,023
+730
+22% +$59.3K
VZ icon
263
Verizon
VZ
$197B
$334K 0.01%
8,196
+1,282
+19% +$52K
VCSH icon
264
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$332K 0.01%
4,163
-64
-2% -$5.11K
ITW icon
265
Illinois Tool Works
ITW
$84.1B
$331K 0.01%
1,345
+138
+11% +$34.4K
GLDM icon
266
SPDR Gold MiniShares Trust
GLDM
$27.5B
$328K 0.01%
+3,837
New +$315K
RWX icon
267
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
$326K 0.01%
11,657
AOK icon
268
iShares Core Conservative Allocation ETF
AOK
$783M
$323K 0.01%
8,060
AVEM icon
269
Avantis Emerging Markets Equity ETF
AVEM
$24.4B
$314K 0.01%
4,083
VHT icon
270
Vanguard Health Care ETF
VHT
$18.5B
$314K 0.01%
1,092
+173
+19% +$48.3K
TTE icon
271
TotalEnergies
TTE
$193B
$309K 0.01%
4,719
+219
+5% +$13.8K
ANET icon
272
Arista Networks
ANET
$199B
$308K 0.01%
2,353
+701
+42% +$96.5K
REGN icon
273
Regeneron Pharmaceuticals
REGN
$72.9B
$308K 0.01%
+399
New +$271K
NEE icon
274
NextEra Energy
NEE
$185B
$307K 0.01%
3,822
-328
-8% -$27.2K
WY icon
275
Weyerhaeuser
WY
$17.6B
$306K 0.01%
+12,932
New +$299K

Similar funds

Aspiriant LLC's Q4 2025 Portfolio in Review

As of Q4 2025, Aspiriant LLC held 329 positions worth $3.48B, up 6.4% from $3.27B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Aspiriant LLC deployed $149M of net new capital in Q4 2025, opening 32 new positions and adding to 177 existing holdings. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 102,726 shares worth $8.47M.

By sector, the portfolio is most concentrated in Technology at 4.1% of assets, up from 4% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $3.77M trimmed.

  • Aspiriant LLC's largest Q4 2025 buy was iShares Core MSCI International Developed Markets ETF: 102,726 shares worth $8.47M.
  • Aspiriant LLC added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $20M increase.
  • Aspiriant LLC's biggest Q4 2025 reduction was iShares National Muni Bond ETF, cutting an estimated $3.77M.
  • Aspiriant LLC fully exited Vanguard Total International Bond ETF in Q4 2025, selling an estimated $906K.
  • Aspiriant LLC's ten largest holdings make up 63% of its $3.48B portfolio in Q4 2025.
  • Aspiriant LLC opened 32 new positions and closed 10 in Q4 2025.
  • Aspiriant LLC's portfolio value rose 6.4% quarter-over-quarter to $3.48B.

Based on Aspiriant LLC's 13F filing for Q4 2025, filed 20 Jan 2026.